Study of the neuroprotective effect of caffeic acid in mice after permanent focal cerebral ischemias

Detalhes bibliográficos
Autor(a) principal: Francisco Diego Pinheiro Fernandes
Data de Publicação: 2014
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações da UFC
Texto Completo: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=12024
Resumo: Brain ischemia results from the acute interruption of blood flow to the brain tissue vascular accident resulting in the decrease of glucose and oxygen to the tissues and consequently to a rapid loss of neurological function. It is the second leading cause of death worldwide and a major cause of disability according to the World Health Organization. Brain stroke pathophysiology involves a complex cascade of events such as inflammation and oxidative stress that lead to neuronal loss and cognitive deficits. Caffeic acid is a natural phenolic compound with antioxidant and anti-inflammatory properties. To evaluate the neuroprotective efficacy of this compound in mice subjected to a permanent middle cerebral artery occlusion (pMCAO), animals were pre-and post-treated with caffeic acid 2, 20 and 60mg/kg, i.p. during 24, 48, 72, 96 or 120h after ischemia. Animals were evaluated at 24 h after the pMCAO for brain infarction and neurological deficit score. At 72 h after the occlusion, animals were evaluated for locomotor activity, working memory and short aversive memory; late aversive memory was evaluated 24 h after the evaluation of short aversive memory. Finally, at 120 h after the event, spatial memory and the expression levels of synaptophysin, SNAP 25 and caspase 3 were evaluated. The treatment with caffeic acid reduced the infarcted area and improved neurological deficit scores. There was no difference in locomotor activity between groups. The working, spatial and late aversive memory deficits were improved by caffeic acid. Furthermore, western blotting data showed that the expression of synaptophysin which correlates with synaptic formation and function, decreased after ischemic insult, caffeic acid inhibited the reduction of synaptophysin expression. The treatment also decreased caspase 3 expression. These results suggest that caffeic acid possesses neuroprotective and anti-dementia properties, at least in part, by preventing the loss of neural cells and synapses in ischemic brain injury.
id UFC_a08ec20f2e581b1706658486742f6ee1
oai_identifier_str oai:www.teses.ufc.br:8220
network_acronym_str UFC
network_name_str Biblioteca Digital de Teses e Dissertações da UFC
spelling info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisStudy of the neuroprotective effect of caffeic acid in mice after permanent focal cerebral ischemiasEfeito neuroprotetor do Ãcido cafeico em camundongos submetidos à isquemia cerebral focal permanente2014-03-26Geanne Matos de Andrade21911258320http://lattes.cnpq.br/9935129797137635SilvÃnia Maria Mendes Vasconcelos29943183349http://lattes.cnpq.br/826426806093087901044971304http://lattes.cnpq.br/4809786703726836Francisco Diego Pinheiro FernandesUniversidade Federal do CearÃPrograma de PÃs-GraduaÃÃo em CiÃncias MÃdicasUFCBRFARMACIABrain ischemia results from the acute interruption of blood flow to the brain tissue vascular accident resulting in the decrease of glucose and oxygen to the tissues and consequently to a rapid loss of neurological function. It is the second leading cause of death worldwide and a major cause of disability according to the World Health Organization. Brain stroke pathophysiology involves a complex cascade of events such as inflammation and oxidative stress that lead to neuronal loss and cognitive deficits. Caffeic acid is a natural phenolic compound with antioxidant and anti-inflammatory properties. To evaluate the neuroprotective efficacy of this compound in mice subjected to a permanent middle cerebral artery occlusion (pMCAO), animals were pre-and post-treated with caffeic acid 2, 20 and 60mg/kg, i.p. during 24, 48, 72, 96 or 120h after ischemia. Animals were evaluated at 24 h after the pMCAO for brain infarction and neurological deficit score. At 72 h after the occlusion, animals were evaluated for locomotor activity, working memory and short aversive memory; late aversive memory was evaluated 24 h after the evaluation of short aversive memory. Finally, at 120 h after the event, spatial memory and the expression levels of synaptophysin, SNAP 25 and caspase 3 were evaluated. The treatment with caffeic acid reduced the infarcted area and improved neurological deficit scores. There was no difference in locomotor activity between groups. The working, spatial and late aversive memory deficits were improved by caffeic acid. Furthermore, western blotting data showed that the expression of synaptophysin which correlates with synaptic formation and function, decreased after ischemic insult, caffeic acid inhibited the reduction of synaptophysin expression. The treatment also decreased caspase 3 expression. These results suggest that caffeic acid possesses neuroprotective and anti-dementia properties, at least in part, by preventing the loss of neural cells and synapses in ischemic brain injury. EFEITO NEUROPROTETOR DO ÃCIDO CAFEICO EM CAMUNDONGOS SUBMETIDOS à ISQUEMIA CEREBRAL FOCAL PERMANENTE. O acidente vascular cerebral (AVC) resulta da interrupÃÃo aguda do fluxo sanguÃneo aos tecidos cerebrais, resultando no decrÃscimo de oxigÃnio e glicose para os tecidos e consequentemente em perda rÃpida da funÃÃo neurolÃgica. à a segunda principal causa de morte no mundo e uma das principais causas de incapacidade fÃsica segundo dados da OrganizaÃÃo mundial de SaÃde. A fisiopatologia do AVC isquÃmico envolve uma complexa cascata de eventos como a inflamaÃÃo e o estresse oxidativo que levarÃo à morte neuronal e dÃficits cognitivos. O Ãcido cafeico à um composto fenÃlico natural com propriedades anti-oxidantes e antiinflamatÃrias. Para avaliar o efeito neuroprotetor deste composto em camundongos submetidos à oclusÃo permanente da artÃria cerebral media, os animais foram prà e pos tratados com Ãcido cafeico nas doses de 2, 20 e 60 mg/kg, i.p., durante 24, 48, 72, 96 ou 120 horas apÃs a isquemia. Os animais foram avaliados 24h apÃs a isquemia para verificar a Ãrea de lesÃo isquÃmica e avaliaÃÃo neurolÃgica. Setenta e duas horas apÃs a oclusÃo, os testes de atividade locomotora, memÃria de trabalho e memÃria aversiva recente foram realizados e a memÃria aversiva tardia realizou-se 24h depois da memÃria recente. Finalmente, 120h apÃs a isquemia, avaliou-se a memÃria espacial e as expressÃes de sinaptofisina, SNAP25 e caspase 3. O tratamento com o Ãcido cafeico reduziu a lesÃo isquemica e melhorou os escores na avaliaÃÃo neurologica. NÃo houve diferenÃa na atividade locomotora entre os grupos. O Ãcido cafeico mostrou proteÃÃo nas memÃrias de trabalho, espacial e aversiva tardia. AlÃm disso, as anÃlises de western blotting mostraram que expressÃo de sinaptofisina, que està relacionada com a funÃÃo e formaÃÃo sinÃptica, diminiu apÃs o insulto isquÃmico e que o acido cafeico inibiu a reduÃÃo da expressÃo de sinaptofisina. Observou-se um aumento na expressÃo de caspase 3 nos animais isquemiados e essa expressÃo foi diminuida pelo tratamento com o Ãcido cafeico. Esses resultados sugerem que as propriedades neuroprotetoras e anti-demencia do Ãcido cafeico possui estÃo relacionadas na prevenÃÃo da perda de celulas neurais e das sinapses no cÃrebro apÃs a lesÃo isquÃmica. FundaÃÃo Cearense de Apoio ao Desenvolvimento Cientifico e TecnolÃgicohttp://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=12024application/pdfinfo:eu-repo/semantics/openAccessporreponame:Biblioteca Digital de Teses e Dissertações da UFCinstname:Universidade Federal do Cearáinstacron:UFC2019-01-21T11:25:17Zmail@mail.com -
dc.title.en.fl_str_mv Study of the neuroprotective effect of caffeic acid in mice after permanent focal cerebral ischemias
dc.title.alternative.pt.fl_str_mv Efeito neuroprotetor do Ãcido cafeico em camundongos submetidos à isquemia cerebral focal permanente
title Study of the neuroprotective effect of caffeic acid in mice after permanent focal cerebral ischemias
spellingShingle Study of the neuroprotective effect of caffeic acid in mice after permanent focal cerebral ischemias
Francisco Diego Pinheiro Fernandes
FARMACIA
title_short Study of the neuroprotective effect of caffeic acid in mice after permanent focal cerebral ischemias
title_full Study of the neuroprotective effect of caffeic acid in mice after permanent focal cerebral ischemias
title_fullStr Study of the neuroprotective effect of caffeic acid in mice after permanent focal cerebral ischemias
title_full_unstemmed Study of the neuroprotective effect of caffeic acid in mice after permanent focal cerebral ischemias
title_sort Study of the neuroprotective effect of caffeic acid in mice after permanent focal cerebral ischemias
author Francisco Diego Pinheiro Fernandes
author_facet Francisco Diego Pinheiro Fernandes
author_role author
dc.contributor.advisor1.fl_str_mv Geanne Matos de Andrade
dc.contributor.advisor1ID.fl_str_mv 21911258320
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/9935129797137635
dc.contributor.referee1.fl_str_mv SilvÃnia Maria Mendes Vasconcelos
dc.contributor.referee1ID.fl_str_mv 29943183349
dc.contributor.referee1Lattes.fl_str_mv http://lattes.cnpq.br/8264268060930879
dc.contributor.authorID.fl_str_mv 01044971304
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/4809786703726836
dc.contributor.author.fl_str_mv Francisco Diego Pinheiro Fernandes
contributor_str_mv Geanne Matos de Andrade
SilvÃnia Maria Mendes Vasconcelos
dc.subject.cnpq.fl_str_mv FARMACIA
topic FARMACIA
dc.description.sponsorship.fl_txt_mv FundaÃÃo Cearense de Apoio ao Desenvolvimento Cientifico e TecnolÃgico
dc.description.abstract.por.fl_txt_mv Brain ischemia results from the acute interruption of blood flow to the brain tissue vascular accident resulting in the decrease of glucose and oxygen to the tissues and consequently to a rapid loss of neurological function. It is the second leading cause of death worldwide and a major cause of disability according to the World Health Organization. Brain stroke pathophysiology involves a complex cascade of events such as inflammation and oxidative stress that lead to neuronal loss and cognitive deficits. Caffeic acid is a natural phenolic compound with antioxidant and anti-inflammatory properties. To evaluate the neuroprotective efficacy of this compound in mice subjected to a permanent middle cerebral artery occlusion (pMCAO), animals were pre-and post-treated with caffeic acid 2, 20 and 60mg/kg, i.p. during 24, 48, 72, 96 or 120h after ischemia. Animals were evaluated at 24 h after the pMCAO for brain infarction and neurological deficit score. At 72 h after the occlusion, animals were evaluated for locomotor activity, working memory and short aversive memory; late aversive memory was evaluated 24 h after the evaluation of short aversive memory. Finally, at 120 h after the event, spatial memory and the expression levels of synaptophysin, SNAP 25 and caspase 3 were evaluated. The treatment with caffeic acid reduced the infarcted area and improved neurological deficit scores. There was no difference in locomotor activity between groups. The working, spatial and late aversive memory deficits were improved by caffeic acid. Furthermore, western blotting data showed that the expression of synaptophysin which correlates with synaptic formation and function, decreased after ischemic insult, caffeic acid inhibited the reduction of synaptophysin expression. The treatment also decreased caspase 3 expression. These results suggest that caffeic acid possesses neuroprotective and anti-dementia properties, at least in part, by preventing the loss of neural cells and synapses in ischemic brain injury.
EFEITO NEUROPROTETOR DO ÃCIDO CAFEICO EM CAMUNDONGOS SUBMETIDOS à ISQUEMIA CEREBRAL FOCAL PERMANENTE. O acidente vascular cerebral (AVC) resulta da interrupÃÃo aguda do fluxo sanguÃneo aos tecidos cerebrais, resultando no decrÃscimo de oxigÃnio e glicose para os tecidos e consequentemente em perda rÃpida da funÃÃo neurolÃgica. à a segunda principal causa de morte no mundo e uma das principais causas de incapacidade fÃsica segundo dados da OrganizaÃÃo mundial de SaÃde. A fisiopatologia do AVC isquÃmico envolve uma complexa cascata de eventos como a inflamaÃÃo e o estresse oxidativo que levarÃo à morte neuronal e dÃficits cognitivos. O Ãcido cafeico à um composto fenÃlico natural com propriedades anti-oxidantes e antiinflamatÃrias. Para avaliar o efeito neuroprotetor deste composto em camundongos submetidos à oclusÃo permanente da artÃria cerebral media, os animais foram prà e pos tratados com Ãcido cafeico nas doses de 2, 20 e 60 mg/kg, i.p., durante 24, 48, 72, 96 ou 120 horas apÃs a isquemia. Os animais foram avaliados 24h apÃs a isquemia para verificar a Ãrea de lesÃo isquÃmica e avaliaÃÃo neurolÃgica. Setenta e duas horas apÃs a oclusÃo, os testes de atividade locomotora, memÃria de trabalho e memÃria aversiva recente foram realizados e a memÃria aversiva tardia realizou-se 24h depois da memÃria recente. Finalmente, 120h apÃs a isquemia, avaliou-se a memÃria espacial e as expressÃes de sinaptofisina, SNAP25 e caspase 3. O tratamento com o Ãcido cafeico reduziu a lesÃo isquemica e melhorou os escores na avaliaÃÃo neurologica. NÃo houve diferenÃa na atividade locomotora entre os grupos. O Ãcido cafeico mostrou proteÃÃo nas memÃrias de trabalho, espacial e aversiva tardia. AlÃm disso, as anÃlises de western blotting mostraram que expressÃo de sinaptofisina, que està relacionada com a funÃÃo e formaÃÃo sinÃptica, diminiu apÃs o insulto isquÃmico e que o acido cafeico inibiu a reduÃÃo da expressÃo de sinaptofisina. Observou-se um aumento na expressÃo de caspase 3 nos animais isquemiados e essa expressÃo foi diminuida pelo tratamento com o Ãcido cafeico. Esses resultados sugerem que as propriedades neuroprotetoras e anti-demencia do Ãcido cafeico possui estÃo relacionadas na prevenÃÃo da perda de celulas neurais e das sinapses no cÃrebro apÃs a lesÃo isquÃmica.
description Brain ischemia results from the acute interruption of blood flow to the brain tissue vascular accident resulting in the decrease of glucose and oxygen to the tissues and consequently to a rapid loss of neurological function. It is the second leading cause of death worldwide and a major cause of disability according to the World Health Organization. Brain stroke pathophysiology involves a complex cascade of events such as inflammation and oxidative stress that lead to neuronal loss and cognitive deficits. Caffeic acid is a natural phenolic compound with antioxidant and anti-inflammatory properties. To evaluate the neuroprotective efficacy of this compound in mice subjected to a permanent middle cerebral artery occlusion (pMCAO), animals were pre-and post-treated with caffeic acid 2, 20 and 60mg/kg, i.p. during 24, 48, 72, 96 or 120h after ischemia. Animals were evaluated at 24 h after the pMCAO for brain infarction and neurological deficit score. At 72 h after the occlusion, animals were evaluated for locomotor activity, working memory and short aversive memory; late aversive memory was evaluated 24 h after the evaluation of short aversive memory. Finally, at 120 h after the event, spatial memory and the expression levels of synaptophysin, SNAP 25 and caspase 3 were evaluated. The treatment with caffeic acid reduced the infarcted area and improved neurological deficit scores. There was no difference in locomotor activity between groups. The working, spatial and late aversive memory deficits were improved by caffeic acid. Furthermore, western blotting data showed that the expression of synaptophysin which correlates with synaptic formation and function, decreased after ischemic insult, caffeic acid inhibited the reduction of synaptophysin expression. The treatment also decreased caspase 3 expression. These results suggest that caffeic acid possesses neuroprotective and anti-dementia properties, at least in part, by preventing the loss of neural cells and synapses in ischemic brain injury.
publishDate 2014
dc.date.issued.fl_str_mv 2014-03-26
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
status_str publishedVersion
format masterThesis
dc.identifier.uri.fl_str_mv http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=12024
url http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=12024
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal do CearÃ
dc.publisher.program.fl_str_mv Programa de PÃs-GraduaÃÃo em CiÃncias MÃdicas
dc.publisher.initials.fl_str_mv UFC
dc.publisher.country.fl_str_mv BR
publisher.none.fl_str_mv Universidade Federal do CearÃ
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da UFC
instname:Universidade Federal do Ceará
instacron:UFC
reponame_str Biblioteca Digital de Teses e Dissertações da UFC
collection Biblioteca Digital de Teses e Dissertações da UFC
instname_str Universidade Federal do Ceará
instacron_str UFC
institution UFC
repository.name.fl_str_mv -
repository.mail.fl_str_mv mail@mail.com
_version_ 1643295189903605760